Background
This study is for HIV+ people who are currently on an Antiretroviral Therapy.

The study involves taking an investigational HIV Maturation Inhibitor for 2 weeks.

Participants who qualify will be paid a total of $2,000 for the study. The study lasts 2 weeks.

Those who qualify will receive routine medical examinations and lab tests in addition to the monetary compensation.

Inclusion Criteria
1. T-Cell count greater than or equal to 100
2. Viral load greater than 2000
3. On your current HIV therapy for at least 8 weeks

For more information please contact Dr. Jacob Lalezari of Quest Clinical Research at (415) 353-0800